Results 81 to 90 of about 78,175 (168)

Exosomal microRNAs as promising indicators of chemoresistance in lung cancer. [PDF]

Ann Med Surg (Lond)
Khalid H, Murtaza M, Amin MHJ.
europepmc   +1 more source

Epigenetic regulation in cancer chemoresistance and combined therapeutic strategies. [PDF]

Front Cell Dev Biol
Jiang L, Yuan Y, Zhang D, Wang J, Jiang X, Shi Y.   +5 more
europepmc   +1 more source

KDM4B/DHX9 promotes chemoresistance in small-cell lung cancer through the MYCN-driven signaling pathway. [PDF]

Oncogene
Lyu Q, Liu H, Shen W, Lin Z, Zhang Y, Ying H, Long Q, Cao X, Zhang J, Shi J, Qiu Z.   +10 more
europepmc   +1 more source

Erratum: Biofunctional study on chemoresistance in esophageal squamous carcinoma cells induced by missense mutation of <i>NOTCH1 p.E450K</i>. [PDF]

J Thorac Dis
Editorial Office.
europepmc   +1 more source

Retraction: Interfering HMGB3 release from cancer-associated fibroblasts by miR-200b represses chemoresistance and epithelial-mesenchymal transition of gastric cancer cells. [PDF]

J Gastrointest Oncol
Ke Y, Mai J, Liu Z, Xu Y, Zhao C, Wang B.   +5 more
europepmc   +1 more source

Response to "Refining the Predictive Role of T2-Weighted Imaging Features in Breast Cancer: A Hypothesis Linking Tumor Characteristics to Extreme Chemoresistance". [PDF]

Korean J Radiol
Park VY, Youn I.
europepmc   +1 more source

Multi-omics integration and Mendelian randomization elucidate the PARP16-UPR axis driving chemoresistancein gastric cancer. [PDF]

Front Oncol
Tao S, Yang H.
europepmc   +1 more source

Continuous adaptive chemotherapy dosing by using planet-formation-inspired dynamics: analytical and <i>in silico</i> insights. [PDF]

Front Oncol
Soares Dos Santos MP, Santos SXF, Bernardo RMC, Vidal JV, Gonçalves G.   +4 more
europepmc   +1 more source

LncRNAs as regulators of chemoresistance and chemosensitivity in triple-negative breast cancer. [PDF]

Genet Mol Biol
Cáceres-Durán MÁ, Rodrigues ACL, Azevedo Junior JC, Alves CD, Calcagno DQ, Borges BDN.   +5 more
europepmc   +1 more source

Kaempferol-based nanocarriers as a potential therapeutic strategy against drug-resistant lung cancer. [PDF]

Cancer Cell Int
Goleij P, Khazeei Tabari MA, Larsen DS, Hadipour M, Rezaee A, Poudineh M, Daglia M, Li T, Khan H, Liu L.   +9 more
europepmc   +1 more source